Capture-stabilize approach for membrane protein SPR assays

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Chu, Ruiyin ^a   Reczek, David ^a   Brondyk, William ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD52 ANTIGEN; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CXCR5; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; LIGAND; MEMBRANE PROTEIN; PEPTIDE; PROTEIN BINDING; TUMOR ANTIGEN;

ANTIBODY AFFINITY; BIOASSAY; CHEMISTRY; HUMAN; KINETICS; METABOLISM; PROCEDURES; PROTEIN DOMAIN; PROTEIN STABILITY; SURFACE PLASMON RESONANCE;

ANTIBODIES; ANTIBODY AFFINITY; ANTIGENS, CD; ANTIGENS, NEOPLASM; BIOLOGICAL ASSAY; GLYCOPROTEINS; HUMANS; KINETICS; LIGANDS; MEMBRANE PROTEINS; PEPTIDES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STABILITY; RECEPTORS, CELL SURFACE; RECEPTORS, CXCR5; SURFACE PLASMON RESONANCE;

EID: 84923298549     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07360     Document Type: Article

References (28)

1. Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nat. Rev. Drug Discov. 5, 993-996 (2006).
2. Hutchings, C. J., Koglin, M. & Marshall, F. H. Therapeuticantibodies directed atG protein-coupled receptors. MAbs 2, 594-606 (2010).
3. Herr, D. R. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers. Int. Rev. Cell Mol. Biol. 297, 45-81 (2012).
4. Eisenstein, M. GPCRs: insane in the membrane. Nat. Meth. 6, 929-932 (2009).
5. Matthew, A. Cooper, Optical biosensors in drug discovery. Nat. Rev. DrugDiscov. 1, 515-528 (2002).
6. Hahnefeld, C., Drewianka, S. & Herberg, F. W. Determination of Kinetic Data Using Surface Plasmon Resonance Biosensors. Meth. in Mol. Medic. 94,299-320 (2004).
7. Phillips, K. S. & Cheng, Q. Recent advances in surface plasmon resonance based techniques for bioanalysis. Anal. Bioanal Chem. 387, 1831-1840 (2007).
8. Jason-Moller, J., Murphy, M. & Bruno, J. OverviewofBiacore Systems and Their Applications. Currt. Protoc. in Prot. Sci. 19.13.1-19.13.14 (2006).
9. Karlsson, O. P. & Lofas, S. Flow-mediated on-surface reconstitution of G-protein coupled receptors for application in surface resonance biosensors. Anal. Biochem. 300, 132-138 (2002).
10. Peter, J. et al. Direct analysis of a GPCR-agonist interaction by surface plasmon resonance. Eur. Bioph. J. 35, 709-712 (2006).
11. Sena, S. et al. A. Functional studies with membrane-bound and detergent-solubilized a2-adrenergic receptors expressed in Sf9 cells. Bioch. et Bioph. Act. (BBA) - Biomem. 1712, 62-70 (2005).
12. Navratilova, I., Sodroski, J. & Myszka, D. G. Solubilization, stabilization, and purification of chemokine receptors using biosensor technology. Anal. Biochem. 339, 271-281 (2005).
13. Rich, R. L. & Myszka, D. G. Higher-throughput, label-free, real-time molecular interaction analysis. Anal. Biochem. 361, 1-6 (2007).
14. Rich, R. L. & Myszka, D. G. Surveyofthe year 2006 commercial optical biosensor literature. J. Mol. Recognit. 20, 300-366 (2007).
15. Rich, A. L., Errey, J., Marshall, F. & Myszka, D. G. Biacore analysis with stabilized G-protein-coupled receptors. Anal. Biochem. 409, 267-272 (2011).
16. Jaakola, V.-P. etal. The 2.6 angstrom crystal structure ofa human A2A adenosine receptor bound to an antagonist. Science 322, 1211-1217 (2008).
17. Grisshammer, R. Purification ofrecombinant G-protein-coupledreceptors. Meth. in Enzymol. 463, 631-645 (2009).
18. Wear, M. A. & Walkinshaw, M. D. Determination of the rate constants for the FK506 binding protein/rapamycin interaction using surface plasmon resonance: an alternative sensor surface for Ni21 -nitrilotriacetic acid immobilization of His- tagged proteins. Anal. Biochem. 371, 250-252 (2007).
19. Yoshitani, N. et al NTA-mediated protein capturing strategy in screening experiments for small organic molecules by surface plasmon resonance. Proteomics 7, 494-499 (2007).
20. Mersich, C. & Jungbauer, A. Generic method for quantification of FLAG-tagged fusion proteins by a real time biosensor. J. Biochem. Biophys. Meth. 70, 555-563 (2007).
21. Rezaie, A. R. & Esmon, C. T. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. J. Biol. Chem. 267, 26104-26109 (1992).
22. Stearns, D. J. et al. The interaction of a Ca21-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca21 binding to both antigen and antibody. J. Biol. Chem. 263, 826-832 (1988).
23. Hermanson, G. T. Bioconjugate Techniques (Academic Press, San Diego, 1996).
24. Vennema, H. et al. Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. EMBO J. 15,2020-2028 (1996).
25. Elizabeth, V., Grgacic, L. & Anderson, D. A. Virus-like particles: Passport to immune recognition. Meth. 40, 60-65 (2006).
26. Nguyen, T.-H. et al. Alemtuzumab induction ofintracellular signaling and apoptosis in malignant B lymphocytes. Leukemia & Lymphoma, 53, 699-709 (2012).
27. Boutin, P. et al. Effects ofanti-CD52 antibodytreatment on immune cell depletion and progression of disease in murine systemic lupus erythematosus. J. Immunol. 188, 119.13 (2012).
28. Mach, H. et al. Disassembly and reassembly ofyeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J. Pharm. Sci. 95, 2195-2206 (2006).